Claudine Serradeil‐Le Gal

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V _1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

Guy Griebel, Jacques Simiand, Claudine Serradeil‐Le Gal et al. · Proceedings of the National Academy of Sciences · 2002 · 462 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist

Claudine Serradeil‐Le Gal, Jean Wagnon, Jacques Simiand et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 210 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Characterization and localization of leptin receptors in the rat kidney

Claudine Serradeil‐Le Gal, Danièle Raufaste, Gabrielle Brossard et al. · FEBS Letters · 1997 · 116 citations · Full text

Life Sciences, Biochemistry, Endocrinology +16

SR120819A, an orally‐active and selective neuropeptide Y Y1 receptor antagonist

Claudine Serradeil‐Le Gal, Gérard Valette, Pierre-Eric Rouby et al. · FEBS Letters · 1995 · 112 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

The Relationship Among Carbon Dioxide Pneumoperitoneum, Vasopressin Release, and Hemodynamic Changes

Claude Mann, G. Boccara, Y. Pouzeratte et al. · Anesthesia & Analgesia · 1999 · 65 citations

Medicine, Pharmacology, Physiology +17